| |
| |
|
| Insider
Information: |
Kazam Joshoa A |
| Relationship: |
Former Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
10 |
|
| Direct
Shares |
2,457,077 |
|
|
Indirect Shares
|
613,318 |
|
|
| Direct
Value |
$8,569,874 |
|
|
|
Indirect Value
|
$5,691 |
|
|
| Total
Shares |
3,070,395 |
|
|
| Total
Value |
$8,575,565 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
TG Therapeutics Inc |
TGTX |
Director |
2005-04-01 |
492,852 |
2005-04-01 |
0 |
Premium* |
|
|
Velcera Inc |
VLCR |
Director |
2007-02-27 |
333,838 |
2007-02-27 |
141,768 |
Premium* |
|
|
Capricor Therapeutics |
CAPR |
Director |
2015-01-21 |
38,084 |
2015-01-21 |
18,896 |
Premium* |
|
|
Arno therapeutics Inc |
ARNI |
Director |
2008-06-03 |
1,129,759 |
2008-06-03 |
452,654 |
Premium* |
|
|
Kite Pharma, Inc. |
KITE |
Director |
2017-10-03 |
0 |
2017-10-03 |
0 |
Premium* |
|
|
Allogene Therapeutics, Inc. |
ALLO |
|
2022-06-15 |
303,063 |
2018-10-15 |
0 |
Premium* |
|
|
Target Hospitality Corp |
TH |
Director |
2019-03-05 |
10,000 |
2019-03-01 |
0 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
Director |
2022-03-07 |
94,481 |
|
0 |
Premium* |
|
|
Tishman Speyer Innovation Corp. Ii |
TSIB |
Director |
2021-02-12 |
25,000 |
2021-02-12 |
0 |
Premium* |
|
|
Ts Innovation Acquisitions Corp. |
TSIAU |
Former Director |
2021-06-04 |
30,000 |
2021-06-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
53 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VLCR |
Velcera Inc |
Director |
– • – |
2007-02-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
333,838 |
|
- |
|
| VLCR |
Velcera Inc |
Director |
– • – |
2007-02-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
141,768 |
|
- |
|
| CAPR |
Capricor Therapeutics |
Director |
– • – |
2007-09-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,066,290 |
|
- |
|
| CAPR |
Capricor Therapeutics |
Director |
– • – |
2007-09-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
779,371 |
|
- |
|
| ARNI |
Arno therapeutics Inc |
Director |
– • – |
2008-06-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
452,654 |
|
- |
|
| ARNI |
Arno therapeutics Inc |
Director |
– • – |
2008-06-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,129,759 |
|
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2014-06-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
437,500 |
|
- |
|
| KRON |
Kronos Bio, Inc. |
Director |
– • – |
2020-10-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,110 |
|
- |
|
| TGTX |
TG Therapeutics Inc |
Director |
– • – |
2005-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
248,827 |
492,852 |
|
- |
|
| CAPR |
Capricor Therapeutics |
Director |
– • – |
2008-12-11 |
4 |
B |
$0.82 |
$3,377 |
D/D |
4,100 |
1,070,390 |
2.31 |
- |
|
| CAPR |
Capricor Therapeutics |
Director |
– • – |
2008-12-12 |
4 |
B |
$1.44 |
$5,907 |
D/D |
4,100 |
1,074,490 |
2.39 |
- |
|
| CAPR |
Capricor Therapeutics |
Director |
– • – |
2008-12-15 |
4 |
B |
$1.05 |
$2,625 |
D/D |
2,500 |
1,076,990 |
2.31 |
- |
|
| CAPR |
Capricor Therapeutics |
Director |
– • – |
2008-12-16 |
4 |
B |
$1.15 |
$3,565 |
D/D |
3,100 |
1,080,090 |
2.31 |
- |
|
| CAPR |
Capricor Therapeutics |
Director |
– • – |
2009-03-12 |
4 |
B |
$0.75 |
$383 |
D/D |
510 |
1,080,600 |
2.31 |
- |
|
| CAPR |
Capricor Therapeutics |
Director |
– • – |
2009-07-07 |
4 |
B |
$0.00 |
$0 |
D/D |
197,628 |
1,278,228 |
2.31 |
- |
|
| CAPR |
Capricor Therapeutics |
Chief Executive Officer |
• • – |
2010-04-22 |
4 |
B |
$0.00 |
$0 |
D/D |
50,000 |
1,328,228 |
2.73 |
- |
|
| CAPR |
Capricor Therapeutics |
President & CEO |
• • – |
2012-03-30 |
4 |
B |
$0.00 |
$0 |
D/D |
125,000 |
1,453,228 |
2.73 |
- |
|
| CAPR |
Capricor Therapeutics |
Director |
– • – |
2013-11-13 |
4 |
A |
$0.00 |
$0 |
D/D |
50 |
29,113 |
0 |
- |
|
| CAPR |
Capricor Therapeutics |
Director |
– • – |
2013-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,875 |
30,988 |
0 |
- |
|
| CAPR |
Capricor Therapeutics |
Director |
– • – |
2015-01-21 |
4 |
B |
$3.52 |
$24,999 |
D/D |
7,096 |
38,084 |
2.39 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2016-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,950 |
216,950 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,410 |
4,360 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-09-28 |
4 |
A |
$0.00 |
$0 |
I/I |
70,050 |
70,050 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-10-03 |
4 |
D |
$180.00 |
$12,609,000 |
I/I |
(70,050) |
0 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-10-03 |
4 |
D |
$180.00 |
$459,540 |
D/D |
(2,553) |
1,807 |
0 |
- |
|
53 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
